Wong; Kamehameha

Patent Applications and Registrations

Patent applications and USPTO patent grants for Wong; Kamehameha.The latest application filed is for "adeno-associated virus vector variants for high efficiency genome editing and methods thereof".

Company Profile

1.12.13

Wong; Kamehameha - Altadena CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Adeno-associated virus vector variants for high efficiency genome editing and methods thereof Grant 11,434,504 - Chatterjee , et al. September 6, 2	2022-09-06
Adeno-associated Virus Vector Variants For High Efficiency Genome Editing And Methods Thereof App 20210079426 - CHATTERJEE; Saswati ; et al.	2021-03-18
Recombinant Adeno-associated Vectors For Targeted Treatment App 20200405882 - Chatterjee; Saswati ; et al.	2020-12-31
Recombinant adeno-associated vectors for targeted treatment Grant 10,596,273 - Chatterjee , et al.	2020-03-24
Adeno-associated virus vector variants for high efficiency genome editing and methods thereof Grant 10,443,075 - Chatterjee , et al. Oc	2019-10-15
Adeno-associated Virus Vector Variants For High Efficiency Genome Editing And Methods Thereof App 20180282765 - CHATTERJEE; Saswati ; et al.	2018-10-04
Recombinant Adeno-associated Vectors For Targeted Treatment App 20180163227 - Chatterjee; Saswati ; et al.	2018-06-14
Adeno-associated virus vector variants for high efficiency genome editing and methods thereof Grant 9,890,396 - Chatterjee , et al. February 13, 2	2018-02-13
Recombinant adeno-associated vectors for targeted treatment Grant 9,839,696 - Chatterjee , et al. December 12, 2	2017-12-12
Recombinant adeno-associated vectors for targeted treatment Grant 9,834,789 - Chatterjee , et al. December 5, 2	2017-12-05
Recombinant adeno-associated vectors for targeted treatment Grant 9,783,825 - Chatterjee , et al. October 10, 2	2017-10-10
Recombinant adeno-associated vectors for targeted treatment Grant 9,777,291 - Chatterjee , et al. October 3, 2	2017-10-03
Recombinant Adeno-associated Vectors For Targeted Treatment App 20170211095 - Chatterjee; Saswati ; et al.	2017-07-27
Recombinant Adeno-associated Vectors For Targeted Treatment App 20170211093 - Chatterjee; Saswati ; et al.	2017-07-27
Recombinant Adeno-associated Vectors For Targeted Treatment App 20170211092 - Chatterjee; Saswati ; et al.	2017-07-27
Recombinant Adeno-associated Vectors For Targeted Treatment App 20170211094 - Chatterjee; Saswati ; et al.	2017-07-27
Adeno-associated Virus Vector Variants For High Efficiency Genome Editing And Methods Thereof App 20170198265 - CHATTERJEE; Saswati ; et al.	2017-07-13
Recombinant adeno-associated vectors for targeted treatment Grant 9,623,120 - Chatterjee , et al. April 18, 2	2017-04-18
Adeno-associated Virus Vector Variants For High Efficiency Genome Editing And Methods Thereof App 20170081680 - CHATTERJEE; Saswati ; et al.	2017-03-23
Recombinant Adeno-associated Vectors For Targeted Treatment App 20150344911 - CHATTERJEE; Saswati ; et al.	2015-12-03
Recombinant adeno-associated vectors for targeted treatment Grant 8,927,514 - Chatterjee , et al. January 6, 2	2015-01-06
CD34-derived recombinant adeno-associated vectors for stem cell transduction and systemic therapeutic gene transfer Grant 8,628,966 - Chatterjee , et al. January 14, 2	2014-01-14
Recombinant Adeno-associated Vectors For Targeted Treatment App 20130096182 - CHATTERJEE; Saswati ; et al.	2013-04-18
Cd34-derived Recombinant Adeno-associated Vectors For Stem Cell Transduction And Systemic Therapeutic Gene Transfer App 20110294218 - Chatterjee; Saswati ; et al.	2011-12-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.